Your browser doesn't support javascript.
loading
Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma.
Xu, Xiaoling; Shen, Wenming; Wang, Ding; Li, Na; Huang, Zhiyu; Sheng, Jiamin; Rucker, A Justin; Mao, Weimin; Xu, Haimiao; Cheng, Guoping.
  • Xu X; Department of Thoracic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Shen W; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Wang D; Department of Cardiothoracic Surgery, Ningbo Yinzhou No. 2 Hospital, Ningbo, China.
  • Li N; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Huang Z; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
  • Sheng J; Shaoxing No. 2 Hospital Medical Community General Hospital, Shaoxing, China.
  • Rucker AJ; Department of Thoracic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Mao W; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Xu H; Department of Thoracic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Cheng G; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Transl Lung Cancer Res ; 11(3): 420-431, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35399567

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article